Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk
Introduction Lung cancer is the world’s leading cause of cancer death. Low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20% in the US National Lung Screening Trial. Here, we present the Yorkshire Lung Screening Trial (YLST), which will address key questions of relevance...
Saved in:
| Main Authors: | Richard D Neal, Kevin Franks, David Torgerson, Rachael L Murray, David R Baldwin, Michael Darby, Henrik Moller, Richard Booton, Una MacLeod, Sam M Janes, Samantha L Quaife, Sebastian Hinde, Matthew EJ Callister, Suzanne Rogerson, Rhian Gabe, Mark Sculpher, Philip AJ Crosbie, Irene Simmonds, Martyn Kennedy, Nazia Ahmed, Ann Cochrane, Mike Messenger, Puvanendran Tharmanathan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/9/e037075.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme
by: Richard D Neal, et al.
Published: (2020-09-01) -
Six-year performance of risk-based selection for lung cancer screening in the Manchester Lung Health Check cohort
by: Matthew Sperrin, et al.
Published: (2024-07-01) -
Protocol for a systematic review and individual participant data meta-analysis for risk factors for lung cancer in individuals with lung nodules identified by low-dose CT screening
by: Matthew Callister, et al.
Published: (2025-01-01) -
A benchmark of deep learning approaches to predict lung cancer risk using national lung screening trial cohort
by: Yifan Jiang, et al.
Published: (2025-01-01) -
LDCT lung cancer screening in populations at different risk for lung cancer
by: Gustavo Borges da Silva Teles, et al.
Published: (2020-09-01)